Afatinib Expanded Access Program

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01649284
Recruitment Status : Approved for marketing
First Posted : July 25, 2012
Last Update Posted : November 30, 2016
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on for this Study
  Recruitment Status : Approved for marketing
  Primary Completion Date : March 2014
  Study Completion Date : March 2014